Tower Research Capital LLC (Trc) Athira Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,073 shares of ATHA stock, worth $3,447. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,073
Previous 9,547
4.96%
Holding current value
$3,447
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ATHA
# of Institutions
58Shares Held
18.5MCall Options Held
24.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY5.4MShares$2.05 Million0.07% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.23MShares$1.23 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$584,4070.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$567,2600.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$567,2600.55% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $14.4M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...